	Actif À Court Terme		Date
Akebia Therapeutics	USD 258.34M	23.68M	2025-09
Alnylam Pharmaceuticals	USD 4.05B	97.85M	2025-12
Celltrion	KRW 5.54T	291.68B	2025-09
Cspc Pharmaceutical	CNY 22.61B	721.94M	2025-06
Deva Holding AS	TRY 9.13B	1.61B	2023-09
Dianthus Therapeutics	USD 413.82M	150.22M	2025-09
Divis Laboratories Ltd	INR 98.43B	2.38B	2025-09
Gilead Sciences	USD 19.89B	1.05B	2025-12
Ionis Pharmaceuticals	USD 2.52B	58.16M	2025-09
Kangmei Pharma	CNY 7.03B	128.34M	2025-09
Karyopharm Therapeutics	USD 89.75M	8.12M	2025-09
Knight Therapeutics	CAD 397.57M	36.96M	2024-09
Laboratorios Farma	EUR 509.33M	128.63M	2023-12
MacroGenics	USD 232.09M	27.15M	2025-09
Malin Corporation	EUR 62.6M	26.7M	2024-12
Medical Developments International	AUD 35.54M	2.13M	2025-06
Neuren Pharmaceuticals	AUD 320.25M	79.08M	2025-06
Organigram Holdings	CAD 284.9M	7.11M	2025-09
Ovoca Bio	EUR 4.96M	2.06M	2022-06
Pfizer	USD 46.92B	3.22B	2025-09
Pharma Mar	EUR 242.88M	6.52M	2025-09
Qiagen NV	USD 2B	535.87M	2025-12
Roche Holding	CHF 38.73B	3.03B	2025-12
Sangamo BioSciences	USD 49.89M	12.3M	2025-06
Sanofi	EUR 30.95B	3.09B	2025-12
Sarepta Therapeutics	USD 2.72B	65.32M	2025-09
Sartorius	EUR 1.72B	449M	2025-09
Sino Biopharmaceutical	CNY 33.82B	9.13B	2025-06
Takeda	JPY 3.12T	195.82B	2025-12
Tilray	USD 688.63M	2.34M	2025-03
Zz Pientze Pharmaceu	CNY 10.7B	1.59B	2025-09

Tectonic Therapeutic Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.